- Home
- BNTX vs WSM Comparison
BNTX vs WSM Comparison
Compare BNTX & WSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- WSM
- Stock Information
- Founded
- BNTX 2008
- WSM 1956
- Country
- BNTX Germany
- WSM United States
- Employees
- BNTX N/A
- WSM N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- WSM Home Furnishings
- Sector
- BNTX Health Care
- WSM Consumer Discretionary
- Exchange
- BNTX Nasdaq
- WSM Nasdaq
- Market Cap
- BNTX 26.4B
- WSM 24.8B
- IPO Year
- BNTX 2019
- WSM N/A
- Fundamental
- Price
- BNTX $96.31
- WSM $199.63
- Analyst Decision
- BNTX Strong Buy
- WSM Buy
- Analyst Count
- BNTX 18
- WSM 16
- Target Price
- BNTX $139.49
- WSM $199.13
- AVG Volume (30 Days)
- BNTX 1.2M
- WSM 1.3M
- Earning Date
- BNTX 11-03-2025
- WSM 08-27-2025
- Dividend Yield
- BNTX N/A
- WSM 1.32%
- EPS Growth
- BNTX N/A
- WSM 9.54
- EPS
- BNTX N/A
- WSM 9.01
- Revenue
- BNTX $3,380,387,551.00
- WSM $7,829,759,000.00
- Revenue This Year
- BNTX N/A
- WSM $2.70
- Revenue Next Year
- BNTX $13.50
- WSM $3.07
- P/E Ratio
- BNTX N/A
- WSM $22.13
- Revenue Growth
- BNTX 6.98
- WSM 3.28
- 52 Week Low
- BNTX $81.20
- WSM $125.33
- 52 Week High
- BNTX $129.27
- WSM $219.98
- Technical
- Relative Strength Index (RSI)
- BNTX 38.20
- WSM 53.36
- Support Level
- BNTX $90.12
- WSM $193.62
- Resistance Level
- BNTX $100.84
- WSM $203.10
- Average True Range (ATR)
- BNTX 4.19
- WSM 5.14
- MACD
- BNTX -0.53
- WSM -0.66
- Stochastic Oscillator
- BNTX 24.99
- WSM 66.81
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About WSM Williams-Sonoma Inc. (DE)
With a retail and direct-to-consumer presence, Williams-Sonoma is a player in the $300 billion domestic home category and $450 billion international home market, focused on expanding its exposure in the B2B ($80 billion total addressable market), marketplace, and franchise areas. Namesake Williams-Sonoma (154 stores) offers high-end cooking essentials, while Pottery Barn (181) provides casual home accessories. West Elm (119) is an emerging concept for young professionals, and Rejuvenation (11) offers lighting and house parts. Brand extensions include Pottery Barn Kids and Pottery Barn Teen (44) as well as Mark & Graham and GreenRow. Williams-Sonoma also has a business-to-business team that supports projects that range from residential to large-scale commercial.